'facta SRL
The score of 'facta shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +246 % Total assets +202 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
'facta's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 28,641 € | ||||
| Equity | 99,625 € | ||||
| Cash | 91,902 € | ||||
| EBITDA | 51,268 € | ||||
| Total assets | 118,724 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 05 Feb 2026
- Year ended 30 Sep 2024filed on 31 Mar 2025
- Year ended 30 Sep 2023filed on 06 Feb 2024
- Year ended 30 Sep 2022filed on 27 Feb 2023
- Year ended 30 Sep 2021filed on 02 Mar 2022
'facta's financial analysis
- Solvency83.9%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of 'facta
'facta's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0863.867.449
- VAT number
- BE0863867449
- Peppol
- Registered · 0208:0863867449 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Mar 2004
- Registered office
- 8400 Ostend
- Latest accounts
- 2025 · filed on 05 Feb 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
'facta (SRL) has been based in Ostend since 2004, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 28,641 € and equity of 99,625 €; its revenue is not published. Its solvency stands at 83.9%, above the median of its sector (46.0%).
Companies similar to 'facta
Companies in the same business, of comparable size and area, outside its group.
- MTLB Healthcare Consulting Business and other management consultancy activities Enghien · balance sheet 298,148 €
- Medi-Support Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Chaudfontaine · balance sheet 149,144 €
- QS Supplements Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Edegem · balance sheet 91,588 €
- Novalab Wholesale of pharmaceutical and medical goods Uccle · balance sheet 113,734 €
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- Accadiss Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Koekelberg · balance sheet 123,919 €
- APIX Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Mont-Saint-Guibert · balance sheet 121,707 €
- Enzo Life Sciences Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 142,693 €
Frequently asked questions about 'facta
What is the revenue of 'facta?
'facta files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of 'facta?
In Belgium, the VAT number is the company number prefixed with BE: BE0863867449 for 'facta, if the company is VAT-registered. Its company number (CBE) is 0863.867.449.
Where is the registered office of 'facta?
According to the CBE register, the registered office of 'facta is in 8400 Ostend.
What is the equity of 'facta?
At the close of the 2025 financial year, the equity of 'facta amounts to 99,625 €, a solvency of 83.9% of total assets.
Who manages 'facta?
The register lists 1 active mandates at 'facta. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of 'facta
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →